SSKN - רווח נקי למניה (EPS TTM) STRATA Skin
STRATA Skin Sciences (SSKN) laser system production is moderately cyclical, while demand for consumables mitigates the impact of crises. The TTM fundamental earnings per share trend reflects current financial results, where the -2.63 mark serves as a key metric. STRATA Skin Sciences is systematically implementing XTRAC excimer complexes featuring automated dose calculation. Industry leadership is driven by unique technologies for targeted action on skin tissues.
SSKN (STRATA Skin Sciences Inc.): פילוחים אנליטיים ודוחות לפי אינדיקטורים
The scale of STRATA Skin Sciences expansion into the psoriasis and vitiligo therapy segment is directly reflected in the company's EPS TTM dynamics. This metric determines the net income per common share over the last twelve months, calculated by dividing the total annual profit by the total number of issued shares. For a medtech business utilizing the XTRAC system, this indicator confirms the effectiveness of B2B contract monetization. Institutional investors utilize this ratio as the primary criterion for the real return on capital.
